The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8
- PMID: 28497911
- PMCID: PMC5583369
- DOI: 10.5534/wjmh.2017.35.2.120
The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8
Abstract
Purpose: We aim to evaluate the efficacy of pollen extract in association with vitamins in patients affected by chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and to evaluate the level of the pro-inflammatory mediators interleukin (IL)-6, IL-8, and IL-10.
Materials and methods: Patients diagnosed with CP/CPPS between January and December 2015 were enrolled in this study. Participants were randomly assigned to receive oral capsules of pollen extract and vitamins (group A) or bromelain (group B) for 3 months. At the enrolment time and 3 months after enrolment, all patients completed questionnaires (the National Institutes of Health Chronic Prostatitis Symptom Index [NIH-CPSI] and the Short Form-36 and underwent urological examinations and microbiological evaluation. Levels of IL-6, IL-8, and IL-10 were evaluated in seminal plasma.
Results: Sixty-five male patients (mean age of 32.7±4.7 years) were analysed (group A, n=32; group B, n=33). At the follow-up examination, 24 of the 32 patients in group A showed a significant reduction in the NIH-CPSI total score compared with 8 of the 33 patients in the bromelain group (p<0.001). Moreover, the mean level of IL-8 was significantly lower in the pollen extract and vitamins group when compared with the bromelain group (298 pg/mL vs. 736 pg/mL, respectively; p<0.001). In group A we found a statistically significant reduction in the levels of IL-8 between enrolment and the follow-up visit (878 pg/mL vs. 298 pg/mL, respectively; p<0.001).
Conclusions: Treatment with pollen extract and vitamins improved the quality of life in CP/CPPS patients by reducing the levels of pro-inflammatory IL-8.
Keywords: Interleukin-8; Pelvic pain; Pollen; Prostatitis.
Copyright © 2017 Korean Society for Sexual Medicine and Andrology
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
The efficacy and tolerability of pollen extract in combination with hyaluronic acid and vitamins in the management of patients affected by chronic prostatitis/chronic pelvic pain syndrome: a 26 weeks, randomized, controlled, single-blinded, phase III study.Minerva Urol Nephrol. 2022 Dec;74(6):780-788. doi: 10.23736/S2724-6051.21.04141-2. Epub 2021 Mar 29. Minerva Urol Nephrol. 2022. PMID: 33781014 Clinical Trial.
-
Effects of pollen extract in association with vitamins (DEPROX 500®) for pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome: results from a pilot study.Urologia. 2013 Apr 24;80 Suppl 22:5-10. doi: 10.5301/RU.2013.10597. Epub 2013 Jan 16. Urologia. 2013. PMID: 23334883 Clinical Trial.
-
Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome.Exp Ther Med. 2014 Oct;8(4):1032-1038. doi: 10.3892/etm.2014.1861. Epub 2014 Jul 24. Exp Ther Med. 2014. PMID: 25187793 Free PMC article.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review.BJU Int. 2019 Aug;124(2):197-208. doi: 10.1111/bju.14492. Epub 2019 Jan 17. BJU Int. 2019. PMID: 30019814
-
Efficacy of acupuncture in the treatment of chronic prostatitis-chronic pelvic pain syndrome: a review of the literature.Int Urol Nephrol. 2019 Dec;51(12):2093-2106. doi: 10.1007/s11255-019-02267-2. Epub 2019 Aug 29. Int Urol Nephrol. 2019. PMID: 31468287 Review.
Cited by
-
Oral pharmacological treatments for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials.EClinicalMedicine. 2022 May 20;48:101457. doi: 10.1016/j.eclinm.2022.101457. eCollection 2022 Jun. EClinicalMedicine. 2022. PMID: 35706494 Free PMC article.
-
Probiotics in the Management of Chronic Bacterial Prostatitis Patients: A Randomized, Double-Blind Trial to Evaluate a Possible Link Between Gut Microbiota Restoring and Symptom Relief.Microorganisms. 2025 Jan 10;13(1):130. doi: 10.3390/microorganisms13010130. Microorganisms. 2025. PMID: 39858898 Free PMC article.
-
Quisqualis indica extract for men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled trial.Investig Clin Urol. 2023 Jan;64(1):20-30. doi: 10.4111/icu.20220290. Investig Clin Urol. 2023. PMID: 36629062 Free PMC article. Clinical Trial.
-
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study.Life (Basel). 2022 Jun 27;12(7):965. doi: 10.3390/life12070965. Life (Basel). 2022. PMID: 35888055 Free PMC article.
-
Is Acupuncture Another Good Choice for Physicians in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome? Review of the Latest Literature.Pain Res Manag. 2020 Mar 9;2020:5921038. doi: 10.1155/2020/5921038. eCollection 2020. Pain Res Manag. 2020. PMID: 32256909 Free PMC article. Review.
References
-
- Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159:1224–1228. - PubMed
-
- Schaeffer AJ. Classification (traditional and National Institutes of Health) and demographics of prostatitis. Urology. 2002;60(6 Suppl):5–6. discussion 6-7. - PubMed
-
- Nickel JC. Role of alpha1-blockers in chronic prostatitis syndromes. BJU Int. 2008;101(Suppl 3):11–16. - PubMed
-
- Tuğcu V, Taşçi AI, Fazlioğlu A, Gürbüz G, Ozbek E, Sahin S, et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS) Eur Urol. 2007;51:1113–1117. discussion 1118. - PubMed
-
- Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62:614–617. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous